companydata.dkcompanydata.dk

BIOPORTO DIAGNOSTICS A/S: Financial statements 2014

CVR: 18645882

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

BIOPORTO DIAGNOSTICS A/S (CVR 18645882) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 18,705,411 and a net result of DKK -22,756,940 compared with DKK -20,607,371 the year before. That is an increase of 12.5% compared with the year before. The profit margin was -121.7%. Equity in the 2014 report amounted to DKK -170,438,583.

Revenue
DKK 18,705,411
Gross Profit
DKK 4,582,314
Profit/Loss
DKK -22,756,940
Equity
DKK -170,438,583
Total Assets
DKK 13,022,577

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201418.7 mio.4.6 mio.-22.8 mio.-170.4 mio.-
201316.6 mio.-1.2 mio.-20.6 mio.-146.4 mio.-
201217.9 mio.11.1 mio.-15.1 mio.-125.8 mio.20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

BIOPORTO DIAGNOSTICS A/S: The 2013 annual report is outApr 11, 2014

BIOPORTO DIAGNOSTICS A/S has published its annual report for 2013. Revenue came to DKK 16,625,213, and the net result was DKK -20,607,371.

BIOPORTO DIAGNOSTICS A/S appoints new auditorApr 10, 2014

As of April 10, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of BIOPORTO DIAGNOSTICS A/S.

Auditor steps down at BIOPORTO DIAGNOSTICS A/SApr 10, 2014

As of April 10, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BIOPORTO DIAGNOSTICS A/S.

Otto Christian Aagaard Rasmussen joins BIOPORTO DIAGNOSTICS A/S as økonomidirektørJan 1, 2014

As of January 1, 2014, Otto Christian Aagaard Rasmussen is registered as økonomidirektør of BIOPORTO DIAGNOSTICS A/S.

About BIOPORTO DIAGNOSTICS A/S

BIOPORTO DIAGNOSTICS A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 1995. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ANTIBODYSHOP A/S and IMMUNOLEX ApS. The management consists of Carsten Buhl. The board consists of Gry Louise Husby Larsen (chair), Carsten Buhl and Klaus Juhl Wulff. The company is owned by BIOPORTO A/S. The company has 29 employees (2026). In 2025, the company reported revenue of DKK 40,286,970 and a net result of DKK -81,398,096 compared with DKK -110,908,377 the year before. Equity in the 2025 report amounted to DKK -837,580,713.

Source: annual report 2025, Danish Business Authority